Drug Profile
AG 1350
Alternative Names: LY 316340; LY 316957Latest Information Update: 21 Sep 2006
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Developer Agouron Pharmaceuticals; Eli Lilly and Company
- Class Antivirals; Benzamides
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 21 Sep 2006 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 16 Feb 2001 Profile reviewed but no significant changes made
- 10 Aug 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)